Anthem Inc Stock News

Let's see if Anthem (ANTM) stock is a good choice for value-oriented investors right now from multiple angles.

Let's see if Anthem (ANTM) stock is a good choice for value-oriented investors right now from multiple angles.

Humana's (HUM) recent dividend hike highlights its sound financial position and sincere efforts to reward shareholders.

On Feb. 15, institutional investment managers with over $100m AUM disclosed their 2021-end positions. Check my list of some of the best-performing hedge funds.

Humana (HUM) is picked by the Louisiana Department of Health for a contract win to help serve the Medicaid members in Louisiana.

The US Justice Department is suing healthcare insurance carrier Anthem for allegedly overcharging Medicare by millions of dollars.

Ensign Group's (ENSG) Q4 results reflect higher revenues, partly offset by steep expenses.

Photo by Online Marketing on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. For many, dealing with a healthcare provider is a confusing, stressful, and overly complex experience. The big insurers can seem like faceless behemoths disconnected from the customers they serve. Profits can seem to be over people. And they are big profits. Healthcare spending accounted for more than 19.7% of U.S. gross domestic product (GDP) in 2020, according to Insider Intelligence. Deloitte believes this could balloon to over $8.3 trillion by 2028. Anthem Inc. (NYSE: ANTM ) reported operating revenue of $136.9 billion in 2021. UnitedHealth Group Inc. (NYSE: UNH ) is expecting to rake in more than … Full story available on Benzinga.com

Anthem Inc (ANTM) shares closed today at 0.4% below its 52 week high of $470.02, giving the company a market cap of $113B. The stock is currently up 0.5% year-to-date, up 63.9% over the past 12 months, and up 212.7% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.4%. Trading Activity Trading volume this week was 2.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -154.9% The company's stock price performance over the past 12 months beats the peer average by 95.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -71.1% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

NEW YORK , Feb. 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENPH, OMC, PENN, CNC, and ANTM. Full story available on Benzinga.com

Tenet Healthcare (THC) Q4 results reflect lower expenses and operational efficiency along with a strong contribution from its Ambulatory Care segment.

Centene's (CNC) fourth-quarter results indicate improved premium and service revenues coupled with sound membership growth. A solid 2022 guidance should impress investors.

Investors looking for a growing stream of income should consider buying UnitedHealth Group.

The recent sell-off presents long-term investors with many robust stocks to buy on the dip. These seven provide a start.

Yacktman's 13F equity portfolio value increased from $10.40B to $11.22B this quarter. Check out Yacktman’s largest five stakes of the portfolio.